Skip to main content
. 2021;21(1):104–112.

Table 1.

Patients demographics and clinical data.

Total sample (Mean ± SD) n = 72 Group EA - Control group (Mean ± SD) n = 24 Group IA (Mean ± SD) n = 24 Group FNB (Mean ± SD) n = 24 P value
Age (years) 72.29 ± 6.51 73.88 ± 6.39 71.54 ± 7.05 71.46 ± 6.02 0.349
BMI (kg.m-2) 30.07 ± 4.81 29.66 ± 4.53 31.22 ± 5.93 29.31 ± 3.68 0.347
Gender (men/women) 16/56 8/16 5/19 3/21 0.257
ASA Classification (ASA-2/ASA-3) 26/46 10/14 7/17 9/15 0.748
Cardiovascular diseases 57 (79.2%) 20 (83.3%) 17 (70.8%) 20 (83.3%) 0.618
Pulmonary diseases 13 (18.1%) 7 (29.2%) 5 (20.8%) 1 (4.2%) 0.065
Endocrine diseases 28 (38.9%) 9 (12.5%) 11 (45.8%) 8 (33.3%) 0.755
Other concomitant diseases 52 (72.2%) 19 (79.2%) 16 (66.7%) 17 (70.8%) 0.717
Smoking 14 (19.4%) 6 (25%) 4 (16.7%) 4 (16.7%) 0.809
Allergies 4 (5.6%) 1 (4.2%) 3 (12.5%) 0 (0%) 0.314

BMI: Body Mass Index; ASA: American Society of Anesthesiologists Classification; SD: Standard Deviation; EA: epidural analgesia; IA: intra-articular analgesia; FNB: femoral nerve block; n: number.